http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NO-20091830-L

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
filingDate 2009-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9709d20d9e46d0d882816ef2f63447fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc9f9cbb162afca27e17d0e0de210e59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba782d7174c6f01ee3bdf00df04fe8ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_acfdeacfcc9e535e74d2fec830e5bd95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83413618aa6a15ca8b99b862f10a8ecf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f811184bcd368b898cfc7aaf03ea193
publicationDate 2009-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber NO-20091830-L
titleOfInvention Spiro-piperidine derivatives as VIa receptor antagonists
abstract The present invention relates to novel indol-2-yl-carbonyl-spiro-piperidine derivatives as VIa receptor antagonists, their preparation, pharmaceutical compositions containing them and their use as medicaments. The active compounds of the present invention are useful for the prevention and / or treatment of anxiety and depressive disorders and other diseases. The compounds of the present invention are represented by the general formula (I) wherein R 1 to R 11, X and Y are as defined in the specification.
priorityDate 2006-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426344311
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23529194

Total number of triples: 33.